REGENERON PHARMACEUTICALS, INC

Lobbying client · New York · filed 2025 to 2026

$3,460,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (200807), not by name.

Firms hired 1

REGENERON PHARMACEUTICALS, INC $3,460,000 6 filings

Reported by year 2 years

2026 $1,270,000 2 filings
2025 $2,190,000 4 filings

Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 6
SENATE 6

Recent filings 6 total

Q2

REGENERON PHARMACEUTICALS, INC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $630,000 expenses · posted Jul 20, 2026

View → Q1

REGENERON PHARMACEUTICALS, INC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $640,000 expenses · posted Apr 20, 2026

View → Q4

REGENERON PHARMACEUTICALS, INC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $610,000 expenses · posted Jan 20, 2026

View → Q3

REGENERON PHARMACEUTICALS, INC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $570,000 expenses · posted Oct 20, 2025

View → Q2

REGENERON PHARMACEUTICALS, INC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $610,000 expenses · posted Jul 21, 2025

View → Q1

REGENERON PHARMACEUTICALS, INC

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $400,000 expenses · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.